Putting the award page together from the records…
Putting the award page together from the records…
TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL.
Up for re-bid: ends 2027-09-29. Recompete brief → · Statistical and Data Coordinating Center (SDCC) for Clinical Research in Infectious Diseases (CRID) ↗
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
5 subawards totaling $20.11M (246.5% of what was obligated), as University of Montana reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Inimmune Corp | $9.19M | 1 | MT | 2025-05-11 | 2025-05-11 |
| Research Foundation for Mental Hygiene, Inc. | $4.93M | 1 | NY | 2026-05-12 | 2026-05-12 |
| University of Washington | $2.59M | 1 | WA | 2025-05-07 | 2025-05-07 |
| Regents of the University of Minnesota | $2.36M | 1 | MN | 2026-05-12 | 2026-05-12 |
| Hennepin Healthcare Research Institute | $1.05M | 1 | MN | 2025-04-18 | 2025-04-18 |
| Date | To | Amount | For |
|---|---|---|---|
| 2025-05-11 | Inimmune Corp | $9.19M | SYNTHETIC AND FORMULATION PROCESS DEVELOPMENT AND SCALE-UP OF THE LEAD FENTANYL VACCINE SUFFICIENT FOR CGMP MANUFACTURE AT A CMO (2) DEVELOPMENT AND QUALIFICATION OF ANALYTICAL ASSAYS NECESSARY FOR API AND FINAL… |
| 2026-05-12 | Research Foundation for Mental Hygiene, Inc. | $4.93M | OPIOID VACCINE FOR TREATING FENTANYL USE DISORDER, REDUCE POISONING AND FATAL OVERDOSE |
| 2025-05-07 | University of Washington | $2.59M | THE PROPOSED STUDIES WILL FOCUS ON DEVELOPMENT OF AN ADJUVANTED VACCINE FORMULATION TARGETING FENTANYL, FENTANYL ANALOGS, HEROIN, HEROIN ANALOGS, OR MIXTURES OF HEROIN/FENTANYL THROUGH EITHER SINGLE-VALENT OR… |
5 actions since 2023-08-03. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-07-27 | P00010 | Administrative change | $0 | EO14398 TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL. |
| 2025-06-11 | P00009 | Administrative change | $0 | TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL. |
| 2024-08-16 | P00008 | Administrative change | $0 | TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL. |
| 2023-08-09 | P00007 | Administrative change | $0 | TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL. |
| 2023-08-03 | P00006 | Option exercised | $8.16M | TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL. |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗
| 2026-05-12 | Regents of the University of Minnesota | $2.36M | VACCINES FOR OPIOD USE DISORDER |
| 2025-04-18 | Hennepin Healthcare Research Institute | $1.05M | THE PURPOSE OF STUDIES AT THE HENNEPIN HEALTHCARE RESEARCH INSTITUTE (HHRI) SITE IS TO TEST LEAD VACCINES TARGETING HEROIN AND FENTANYL FOR THEIR ABILITY TO REDUCE THE ADDICTIVE EFFECTS OF THESE DRUGS IN RATS. IN… |